Former Prime Minister Jean Chrétien and former Ontario premier and MP Bob Rae were among the prominent attendees at Monday’s launch for the Dal-hosted MacEachen Institute: a nationally focused, non-partisan interdisciplinary institute supporting progressive public policy and citizen engagement.

A clinical trial led by Dal cardiology professor Dr. John Sapp has identified a superior treatment for ventricular tachycardia, a life-threatening heart condition that affects about 50,000 Canadians.

Physics prof Jeff Dahn and his team represent one of the world’s most renowned hubs of expertise in battery technology, developing material now used in about one-third of all lithium-ion (Li-ion) battery cells produced worldwide. On Thursday, he was announced as one of six inaugural recipients of Canada's new Governor General's Innovation Award.

Dal's Industry Liaison and Innovation office hosted its first drug development boot camp this week, bringing together AV¾ãÀÖ²¿ researchers and pharmaceutical industry reps to discuss successful partnerships across academic and industry boundaries.

Chemistry's Axel Becke, one of the most cited researchers in the world and last year's recipient of NSERC's Herzberg Medal, has been awarded the Canada Council for the Arts' Killam Prize in the Natural Sciences — one of Canada's most prestigious scholarly honours.